Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BFB Health's earnings before interest and taxes (EBIT) for the
six
months ended in Dec. 2025 was HK$-17.62 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-17.56 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
BFB Health's annualizedROC % for the quarter that ended in Dec. 2025 was 9.29%.
BFB Health's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -1,885.79%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
BFB Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -3.38%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFB Health EBIT Related Terms
BFB Health EBIT Historical Data
* Premium members only.
The historical data trend for BFB Health's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, BFB Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BFB Health EV-to-EBIT vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, BFB Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where BFB Health's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-17.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFB Health (HKSE:00205) has a EBIT of HK$-17.56 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BFB Health.
Is BFB Health's EBIT too high?
BFB Health's current EBIT is HK$-17.56 Mil. Overall, BFB Health has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BFB Health's EBIT compare to APP and OMC?
BFB Health's EBIT of HK$-17.56 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Media - Diversified company?
A good EBIT depends on the Media - Diversified industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BFB Health. BFB Health's current EBIT is HK$-17.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BFB Health stock overvalued right now?
Based on GuruFocus' analysis, BFB Health (HKSE:00205) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.55 — trading 292.9% above its estimated fair value. The current EBIT is HK$-17.56 Mil. BFB Health's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For BFB Health (HKSE:00205), the current EBIT is HK$-17.56 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BFB Health (HKSE:00205) Overvalued in 2026?
Based on GuruFocus' analysis, BFB Health stock appears to be overvalued.
The current stock price of HK$0.55 is trading 292.9% above its estimated GF Value™ of HK$0.14.
GuruFocus considers BFB Health to be Significantly Overvalued.
Key valuation signals for HKSE:00205:
EBIT: HK$-17.56 Mil
GF Value™: HK$0.14 vs. price of HK$0.55 (292.9% above fair value)
No single metric tells the full story. See the HKSE:00205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BFB Health Ltd is an investment holding company. Along with its subsidiaries, it operates in the following reportable segments: Provision of advertising and e-commerce business, Provision of securities broking services, and Money lending. Maximum revenue is derived from the Provision of advertising and e-commerce business, which generates the majority of its revenue from the sales of health and wellness products, through e-commerce channels, and the rest comes from the provision of advertising services, sales of books and magazines, and multi-channel network activities. Geographically, the Group generates maximum revenue from the People's Republic of China (PRC), and the rest from Hong Kong.
36GF Score
Get the complete analysis for HKSE:00205
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00205 has been successfully added to your 
